Immobilization hypercalcemia-associated acute renal failure in a patient with chronic tophaceous gout

Renal Failure

Volumn 31, Issue 9, 2009, Pages 855-857

  Lee, Kyung Ae ^a   Yoo, Wan Hee ^a  

^a Chonbuk National University Medical School and Hospital   (South Korea)

Author keywords

Acute renal failure; Bisphosphonate; Chronic tophaceous gout; Hypercalcemia; Immobilization

Indexed keywords

ALLOPURINOL; BENZBROMARONE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; COLCHICINE; FUROSEMIDE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FLUID THERAPY; FOLLOW UP; GOUT; HOSPITAL DISCHARGE; HUMAN; HYPERCALCEMIA; IMMOBILIZATION; MALE; PRIORITY JOURNAL; REHABILITATION;

CHRONIC DISEASE; GOUT; HUMANS; HYPERCALCEMIA; IMMOBILIZATION; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED;

EID: 71049147564     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903151393     Document Type: Article

References (21)

1. Hutton E. Evaluation and management of hypercalcemia. JAAPA. 2005;18:30-35.
2. Albright F, Burnett CH, Cope O. Acute atrophy of bone (osteoporosis) simulating hyperparathyroidism. J Clin Endocrinol. 1941;1:711-716.
3. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: An example of resorptive hypercalciuria. N Engl J Med. 1982;306:1136-1140.
4. Kedlaya D, Brandstater ME, Lee JK. Immobilization hypercalcemia in incomplete paraplegia: Successful treatment with pamidronate. Arch Phys Med Rehabil. 1998;79:222-225.
5. Sato Y, Asoh T, Kaji M, Oizumi K. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res. 2000;15:2487-2494.
6. Cheng CJ, Chou CH, Lin SH. An unrecognized cause of recurrent hypercalcemia: Immobilization. South Med J. 2006;99:371-374.
7. Rose BD. Pathophysiology of renal disease. 2nd ed. New York: McGraw-Hill; 1987:418-425.
8. Kjellstrand CM, Campbell DC, von Hartitzsch B, Buselmeier TJ. Hyperuricemic acute renal failure. Arch Intern Med. 1974;133:349-359.
9. Wang W, Li C, Kwon TH, et al. Reduced expression of renal Na+ transporters in rats with PTH-induced hypercalcemia. Am J Physiol. 2004;286:F534-F545.
10. Lin SH, Lin YF, Cheema-Dhadli S, Davids MR, Halperin ML. Hypercalcaemia and metabolic alkalosis with betel nut chewing: Emphasis on its integrative pathophysiology. Nephrol Dial Transplant. 2002;17:708-714.
11. Sato Y. Abnormal bone and calcium metabolism in patients after stroke. Arch Phys Med Rehabil. 2000;81:117-121.
12. Sachdeva A, Goeckeritz BE, Oliver AM. Symptomatic hypercalcemia in a patient with chronic tophaceous gout: A case report. Cases J. 2008;1:72.
13. Sharma OP. Hypercalcemia in granulomatous disorders: A clinical review. Curr Opin Pulm Med. 2000;6:442-447.
14. Motoyama K, Inaba M, Emoto M, Morii H, Nishizawa Y. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement. Intern Med. 2002;41:449-452.
15. Kaul S, Sockalosky JJ. Human synthetic calcitonin therapy for hypercalcemia of immobilization. J Pediatr. 1995;126: 825-827.
16. Bikle DD, Halloran BP. The response of bone to unloading. J Bone Miner Metab. 1999;17:233-244.
17. Krieger NS, Sessler NE, Bushinsky DA. Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol. 1992;262:F442-F448.
18. Raisz LG. Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J Clin Invest. 1965;44:103-116.
19. Zeigler R. Hypercalcemic crisis. J Am Soc Nephrol. 2001;12: S3-S9.
20. Benabe JE, Martinez-Maldonado M. Hypercalcemic nephropathy. Arch Intern Med. 1978;138:777-779.
21. Lins LE. Reversible renal failure caused by hypercalcemia. A retrospective study. Acta Med Scand. 1978;203:309-314.